|
Real-time Estimate
Cboe Europe
12:45:51 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 117.40 CHF | +0.91% |
|
-2.89% | +6.15% |
| 03/10 | Healthcare Stocks Fall Slightly -- Healthcare Roundup | DJ |
| 03/10 | Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | DJ |
| Market Cap | 27TCr 24TCr 22TCr 20TCr 38TCr 25,63400Cr 38TCr 2,67600Cr 1,03700Cr 13,10500Cr 1,00100Cr 98TCr 42,05700Cr | P/E 2026 * |
19.8x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 30TCr 26TCr 25TCr 23TCr 42TCr 28,65300Cr 43TCr 2,99100Cr 1,15900Cr 14,64800Cr 1,11900Cr 1,09500Cr 47,01000Cr | EV / Sales 2026 * |
5.17x | EV / Sales 2027 * | 4.8x |
| Free-Float |
91.66% | Yield 2026 * |
3.09% | Yield 2027 * | 3.23% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Xetra
| NOT | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
OTC Markets
| NVSEF | Delayed | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| NOT | Delayed | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
London S.E.
| 0QLR | Delayed | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +0.83% | ||
| 1 week | -2.89% | ||
| Current month | -3.02% | ||
| 1 month | -10.22% | ||
| 3 months | -9.05% | ||
| 6 months | -5.57% | ||
| Current year | +6.15% |
| 1 week | 116.2 |  | 122.54 |
| 1 month | 110.3 | | 127.22 |
| Current year | 107.68 | | 132.68 |
| 1 year | 97.05 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.91% | -2.89% | +10.57% | +32.81% | 27TCr | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,01900Cr | |
| -1.02% | -5.60% | +35.72% | +64.63% | 62TCr | |
| +1.11% | -0.58% | +12.36% | +77.95% | 46TCr | |
| +0.34% | -3.01% | +61.79% | +41.24% | 36TCr | |
| +0.10% | -4.05% | +20.54% | +41.71% | 33TCr | |
| +0.19% | -5.43% | -6.17% | +8.98% | 24TCr | |
| -1.04% | -2.79% | +35.30% | +51.84% | 22TCr | |
| -1.87% | -4.10% | +28.44% | +93.66% | 18TCr | |
| -0.77% | -2.52% | -36.39% | -61.32% | 17TCr | |
| Average | -0.27% | -3.36% | +19.82% | +46.65% | 38.63TCr | |
| Weighted average by Cap. | -0.26% | -3.46% | +26.26% | +64.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.77TCr 5.13TCr 4.78TCr 4.36TCr 8.22TCr 5,54600Cr 8.3TCr 58TCr 22TCr 2,83500Cr 22TCr 21TCr 9,09900Cr | 6.14TCr 5.46TCr 5.09TCr 4.64TCr 8.76TCr 5,90600Cr 8.84TCr 62TCr 24TCr 3,01900Cr 23TCr 23TCr 9,69000Cr |
| Net income | 1.42TCr 1.26TCr 1.18TCr 1.08TCr 2.03TCr 1,36800Cr 2.05TCr 14TCr 5.53TCr 70TCr 5.34TCr 5.23TCr 2,24400Cr | 1.58TCr 1.4TCr 1.31TCr 1.19TCr 2.25TCr 1,51800Cr 2.27TCr 16TCr 6.14TCr 78TCr 5.93TCr 5.8TCr 2,49100Cr |
| Net Debt | 3.14TCr 2.79TCr 2.6TCr 2.37TCr 4.48TCr 3,01900Cr 4.52TCr 32TCr 12TCr 1,54300Cr 12TCr 12TCr 4,95300Cr | 2.82TCr 2.51TCr 2.34TCr 2.13TCr 4.02TCr 2,71300Cr 4.06TCr 28TCr 11TCr 1,38700Cr 11TCr 10TCr 4,45100Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | CHF 116.94 | +0.52% | 73,905 |
| 02/26/02 | CHF 116.34 | -1.46% | 25,95,469 |
| 01/26/01 | CHF 118.06 | -1.58% | 28,20,997 |
| 30/26/30 | CHF 119.96 | -0.79% | 42,58,547 |
| 29/26/29 | CHF 120.92 | -0.40% | 26,43,402 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
